Clinical trials - Press Releases

Date	Title	Company
06-May-2020	Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University	Santhera Pharmaceuticals
06-May-2020	Antabio Receives QIDP Designation from the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens	Antabio SAS
06-May-2020	Trio of Awards for Synergy Vision in Just One (Four-Day-Working) Week … prestigious Platinum from Investors in People, UK’s 3rd Best Small Workplace for 2020 by Great Place to Work® and platinum and gold Muse Creative Awards …	Synergy Vision (SV)
05-May-2020	Richmond Research Institute partnering to ensure faster COVID-19 point of care testing and longer-term immunity studies	Richmond Research Institute
05-May-2020	Stilla Technologies offers a digital PCR solution to detect Covid-19 infections more sensitively and more accurately than the current RT-PCR method	Stilla Technologies
05-May-2020	CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer	CEL-SCI Corporation
05-May-2020	Biomaterial immune control discoveries could reduce implant rejection	The University of Nottingham
05-May-2020	Vaxxel acquires Transgene's DuckCelt®-T17 cell line to develop industrial-scale vaccines against respiratory viruses	Vaxxel SAS
05-May-2020	Freeline receives Orphan Drug Designation from the FDA for FLT190 for the treatment of Fabry Disease	Freeline
05-May-2020	Sensyne Health announces launch of new BPm-Health™ free-of-charge across NHS in response to COVID-19 pandemic	Sensyne Health
05-May-2020	Vifor Pharma announces Akebia’s Positive top-line results from global phase-III program of vadadustat for treatment of anaemia due to Chronic Kidney Disease in adult dialysis-dependent patients	Vifor Pharma
05-May-2020	Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program	Pfizer and BioNTech
05-May-2020	OMRON Healthcare announces WheezeScan, world’s first wheeze detection device	OMRON Healthcare
01-May-2020	Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages 6 Months and 18 Years With the R117H Mutation in the CFTR Gene	Vertex Pharmaceuticals
30-Apr-2020	CloudLIMS Accelerates COVID-19 Testing & Research with its Preconfigured, Rapid Deployment COVID-19 LIMS	CloudLIMS
30-Apr-2020	Account Executive	PHARMASEAL
29-Apr-2020	BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany	BioNTech SE
29-Apr-2020	SANGAMO THERAPEUTICS ANNOUNCES PRESENTATIONS AT 2020 ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY	SANGAMO THERAPEUTICS
29-Apr-2020	COMMENT: BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19)	Mewburn
29-Apr-2020	FDA approves ONGENTYS® ▼ (opicapone)	BIAL